Form 8-K - Current report:
SEC Accession No. 0001193125-25-025524
Filing Date
2025-02-13
Accepted
2025-02-13 06:01:47
Documents
13
Period of Report
2025-02-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d927492d8k.htm   iXBRL 8-K 21955
  Complete submission text file 0001193125-25-025524.txt   139217

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA agio-20250210.xsd EX-101.SCH 2832
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20250210_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20250210_pre.xml EX-101.PRE 10800
15 EXTRACTED XBRL INSTANCE DOCUMENT d927492d8k_htm.xml XML 3503
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 25616955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)